TITLE

Disability and quality of life in Charcot-Marie-Tooth disease type 1

AUTHOR(S)
Pfeiffer, G.; Wicklein, E. M.; Ratusinski, T.; Schmitt, L.; Kunze, K.
PUB. DATE
April 2001
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Apr2001, p548
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67027797

 

Related Articles

  • Depression and Charcot-Marie-Tooth disease. Vinci, P.; Gargiulo, P.; Colazza, G. B.; Padua, L.; Pazzaglia, C. // Neurological Sciences;Oct2007, Vol. 28 Issue 5, p295 

    Two letters to the editor are presented in response to the article "Variables influencing quality of life and disability in Charcot-Marie-Tooth (CMT) patients: Italian multicentre study."

  • Quality of Life in Children With Charcot-Marie-Tooth Disease. Burns, Joshua; Ryan, Monique M.; Ouvrier, Robert A. // Journal of Child Neurology;Mar2010, Vol. 25 Issue 3, p343 

    The authors studied the health-related quality of life of children aged 5 to 18 years with Charcot-Marie-Tooth disease of varying types and severity and compared it with the general pediatric population. To capture and compare the quality-of-life data across a broad range of ages, the Child...

  • Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P2 phosphatase FIG4. Nicholson, Garth; Lenk, Guy M.; Reddel, Stephen W.; Grant, Adrienne E.; Towne, Charles F.; Ferguson, Cole J.; Simpson, Ericka; Scheuerle, Angela; Yasick, Michelle; Hoffman, Stuart; Blouin, Randall; Brandt, Carla; Coppola, Giovanni; Biesecker, Leslie G.; Batish, Sat D.; Meisler, Miriam H. // Brain: A Journal of Neurology;Jul2011, Vol. 134 Issue 7, p1959 

    Charcot–Marie–Tooth disease is a genetically heterogeneous group of motor and sensory neuropathies associated with mutations in more than 30 genes. Charcot–Marie–Tooth disease type 4J (OMIM 611228) is a recessive, potentially severe form of the disease caused by...

  • Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene. Vinci, Paolo; Lapi, Giovanni // Journal of Anaesthesiology Clinical Pharmacology;Apr2011, Vol. 27 Issue 2, p286 

    A letter to the editor about anesthetic management in Charcot-Marie-Tooth disease (CMT) type 2 attributed to a mutation in the mitofusin-2 gene is presented.

  • Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two generations. Panas, M.; Karadima, G.; Kalfakis, N.; Floroskufi, P.; Vassilopoulos, D. // Journal of Neurology;Apr2004, Vol. 251 Issue 4, p484 

    Presents a letter to the editor about Charcot-Marie-Tooth disease type 1A with central nervous system involvement in two regions.

  • VyÅ¡etÅ™ení kardiovaskulární reaktivity u pacientů s dÄ›dičnou neuropatií. Horáček, O.; Jílková, D.; Matouš, M.; Mazanec, R.; Nedělka, J.; Kolář, P.; Nedělka, T. // Rehabilitation & Physical Medicine / Rehabilitace a Fyzikalni Le;2014, Vol. 21 Issue 3, p130 

    The hereditary motor and sensitive neuropathy, morbus Charcot Marie Tooth, is one of the most common neuromuscular diseases in the world. In recent years a proofs suggesting, that illness has an autonomic component were found. On a group of 17 patients suffering from Charcot Marie Tooth disease...

  • Factors Associated With Foot and Ankle Strength in Healthy Preschool-Age Children and Age-Matched Cases of Charcot-Marie-Tooth Disease Type 1A. Rose, Kristy J.; Burns, Joshua; North, Kathryn N. // Journal of Child Neurology;Apr2010, Vol. 25 Issue 4, p463 

    Charcot-Marie-Tooth disease affects foot and ankle strength from the earliest stages of the disease; however, little is known about factors influencing normal strength development or the pathogenesis of foot weakness and deformity in Charcot-Marie-Tooth disease. The authors investigated factors...

  • Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Padua, L.; Aprile, I.; Cavallaro, T.; Commodari, I.; la Torre, G.; Pareyson, D.; Quattrone, A.; Rizzuto, N.; Vita, G.; Tonali, P.; Schenone, A. // Neurological Sciences;Dec2006, Vol. 27 Issue 6, p417 

    The purpose of this study was to assess the variables that influence quality of life (QoL) and disability in patients with Charcot-Marie-Tooth disease (CMT). We performed a prospective multicentre study using validated clinical disability and QoL measurements. Multivariate analysis was performed...

  • Charcot Marie Tooth Disease Type 1 - Rare but Commonest Hereditary Neuropathy. Bhattacharjee, Shakya; Saha, Shankar Prasad // Al Ameen Journal of Medical Sciences;2012, Vol. 5 Issue 1, p103 

    Objective: To present a case of Charcot Marie Tooth Disease. Backgrounds: A 22 years old boy presented with very slowly progressive symmetrical weakness of both lower limbs with distal muscular atrophy. He has a family member with similar problem. Methods: The patient was clinically examined and...

  • Obstructive sleep apnoea, restless leg syndrome and Charcot-Marie-Tooth disease type 1: important associations. Reilly, Mary M. // Journal of Neurology, Neurosurgery & Psychiatry;Mar2014, Vol. 85 Issue 3, p245 

    The author discusses the association between obstructive sleep apnoea, restless leg syndrome (RLS) and Charcot-Marie-Tooth disease type 1 (CMT1). Topics discussed include the apnoea–hypopnoea index (AHI), the functional disability scale (FDS) and the neurological disability. The author...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics